We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Rapid Diagnostic Tests Evaluated for Pregnancy Malaria

By LabMedica International staff writers
Posted on 01 Nov 2012
Print article
Accurate diagnosis and prompt treatment of pregnancy-associated malaria (PAM) is essential to avert adverse nativity outcomes.

Rapid diagnostic tests (RDTs) are an ideal diagnostic complement to microscopy, due to their ease of use and adequate sensitivity in detecting even submicroscopic infections.

Scientists at the National Institute of Medical Research (Tanga, Tanzania) collaborated with other international centers to evaluate the immunochromatographic RDTs under field conditions. A cohort of 924 pregnant women was followed up from enrolment until delivery, and a total of 5,905 samples were collected. Of those, 5,167 venous and 388/650 placental blood samples, for which there were complete RDT and microscopy datasets, were randomly selected for analysis.

The accuracy and reliability of RDTs in diagnosing PAM was evaluated using microscopy and nested polymerase chain reaction (PCR). Venous and placental blood samples evaluated by histidine rich protein 2 (HRP-2) and parasite lactate dehydrogenase (pLDH) based RDT Parascreen, (Zephyr Biomedicals; Goa, India) or HRP-2 only RDTs Paracheck Pf (Orchid Biomedical Systems; Mumbai, India) and ParaHITf (Span Diagnostics Ltd.; Surat, India).

Overall 91 of 5,555 (1.6%) samples were positive for malarial parasite antigen based on RDTs, whereas 49 of 5,555 (0.9%) were positive by microscopy. Of the 91 RDT positive samples, 50.5% were microscopy positive, while 49.5% were microscopy negative. To test whether the 45 microscopy negative but RDT positive samples were genuinely negative or false positive, a species diagnostic PCR assay was performed. Intriguingly, 19 of the 45 (42.2%) microscopy negative were positive by PCR and only three samples were positive by microscopy but negative by RDT.

The authors concluded that RDTs outperform expert microscopy in detecting asymptomatic Plasmodium falciparum in pregnant women. Given the difficulties in establishing reliable microscopy based diagnostic services, RDTs are good alternative for the detection and in the management of malaria infections in pregnant women. RDTs can both be used to detect infections not cleared by intermittent preventive treatment during pregnancy (IPTp) or to detect infections where the malaria endemicity is too low to warrant IPTp. The study was published on June 21, 2012, in the Malaria Journal .

Related Links:
Tanzania National Institute of Medical Research
Zephyr Biomedicals
Orchid Biomedical Systems

Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Biological Indicator Vials
BI-O.K.
New
Centromere B Assay
Centromere B Test

Print article

Channels

Molecular Diagnostics

view channel
Image: Researcher Kanta Horie places a sample in a mass spectrometer that measures protein levels in blood plasma and other fluids (Photo courtesy of WashU Medicine)

Highly Accurate Blood Test Diagnoses Alzheimer’s and Measures Dementia Progression

Several blood tests are currently available to assist doctors in diagnosing Alzheimer's disease in individuals experiencing cognitive symptoms. However, these tests do not provide insights into the clinical... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.